Trial Profile

An exploratory, double blind, randomized, placebo-controlled, 2-way cross-over study to assess the effect of repeat-dose inhaled indacaterol maleate [indacaterol] (300 mcg) on dynamic and static lung hyperinflation, subjective breathlessness and health status in patients with COPD

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Sep 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2007-004684-22).
29 Aug 2011 Trial phase changed from III to II as reported by ClinicalTrials.gov.
13 Oct 2009 Status changed from recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com